Rhenman & Partners Asset Management AB Has $545,000 Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Rhenman & Partners Asset Management AB decreased its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 87.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,750 shares of the company’s stock after selling 92,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Acadia Healthcare were worth $545,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Lindbrook Capital LLC grew its holdings in Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after acquiring an additional 671 shares during the period. Blue Trust Inc. boosted its position in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares during the last quarter. Signaturefd LLC lifted its stake in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after buying an additional 1,004 shares during the period. Finally, Fifth Third Bancorp boosted its holdings in Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after buying an additional 454 shares during the last quarter.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Bank of America cut their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. KeyCorp dropped their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, March 3rd. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Finally, TD Cowen decreased their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $52.19.

Acadia Healthcare Price Performance

Shares of ACHC opened at $27.37 on Friday. The firm has a market capitalization of $2.54 billion, a PE ratio of 8.97, a PEG ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a fifty-two week low of $26.72 and a fifty-two week high of $82.41. The company’s 50-day moving average is $35.62 and its 200-day moving average is $43.59.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.